Accueil > Actualité
Actualite financiere : Actualite bourse

J&J: researchers mobilised around 'Omicron' variant

( - J&J has announced that it is evaluating the efficacy of its vaccine and booster doses against the new "Omicron" variant of the coronavirus.

While the company says that it is "confident" about the strength of the immune response induced by its vaccine, J&J says its researchers have already begun work to design and develop a new vaccine against Omicron, i.e. a new serum that could rapidly progress to clinical studies if necessary.

Copyright (c) 2021 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.